Cargando…

PROMETHEUS: Long-Term Exacerbation and Mortality Benefits of Implementing Single-Inhaler Triple Therapy in the US COPD Population

Background: The US population includes 24 million to 29 million people with diagnosed and undiagnosed chronic obstructive pulmonary disease (COPD). Studies have demonstrated the safety and efficacy of single-inhaler triple therapy (SITT) in reducing COPD exacerbations. Long-term population implicati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Criner, Gerard, Martinez, Fernando, Gandhi, Hitesh, Feigler, Norbert, Pyenson, Bruce, Emery, Matthew, Gupta, Umang, Vaduganathan, Muthiah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Columbia Data Analytics, LLC 2023
Materias:	Respiratory Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879267/ https://www.ncbi.nlm.nih.gov/pubmed/36742194 http://dx.doi.org/10.36469/001c.55635

Ejemplares similares

β-Blockers for the prevention of acute exacerbations of chronic obstructive pulmonary disease (βLOCK COPD): a randomised controlled study protocol
por: Bhatt, Surya P, et al.
Publicado: (2016)

Prevalence and incidence of COPD in smokers and non-smokers: the Rotterdam Study
por: Terzikhan, Natalie, et al.
Publicado: (2016)

Inhaler technique education in elderly patients with asthma or COPD: impact on disease exacerbations—a protocol for a single-blinded randomised controlled trial
por: Maricoto, Tiago, et al.
Publicado: (2019)

Health-care Resource Requirements and Potential Financial Consequences of an Environmentally Driven Switch in Respiratory Inhaler Use in England
por: Attar-Zadeh, Darsuh, et al.
Publicado: (2021)

Use and persistence of single and multiple inhaler triple therapy prescribed for patients with COPD in France: a retrospective study on THIN database (OPTI study)
por: Deslee, Gaétan, et al.
Publicado: (2023)

The five-repetition sit-to-stand test is a predictive factor of severe exacerbations in COPD
por: Medina-Mirapeix, Francesc, et al.
Publicado: (2021)

Relationship between heart failure and the risk of acute exacerbation of COPD
por: Axson, Eleanor L, et al.
Publicado: (2021)

The impact of exacerbation frequency on mortality following acute exacerbations of COPD: a registry-based cohort study
por: Schmidt, Sigrun Alba Johannesdottir, et al.
Publicado: (2014)

Sputum PGP is reduced by azithromycin treatment in patients with COPD and correlates with exacerbations
por: O'Reilly, Philip J, et al.
Publicado: (2013)

Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study
por: Strange, Charlie, et al.
Publicado: (2023)

Acute Exacerbation and Respiratory InfectionS in COPD (AERIS): protocol for a prospective, observational cohort study
por: Bourne, Simon, et al.
Publicado: (2014)

A prospective, observational cohort study of the seasonal dynamics of airway pathogens in the aetiology of exacerbations in COPD
por: Wilkinson, Tom M A, et al.
Publicado: (2017)

Stratified assessment of the role of inhaled hypertonic saline in reducing cystic fibrosis pulmonary exacerbations: a retrospective analysis
por: Dmello, Dayton, et al.
Publicado: (2011)

Preventing clinically important deterioration with single-inhaler triple therapy in COPD
por: Naya, Ian, et al.
Publicado: (2018)

Phase II study of tight glycaemic control in COPD patients with exacerbations admitted to the acute medical unit
por: Archer, John R H, et al.
Publicado: (2011)

Benefits of the ‘village’: a qualitative exploration of the patient experience of COPD in rural Australia
por: Glenister, Kristen, et al.
Publicado: (2019)

Optimising treatment for COPD – new strategies for combination therapy
por: Welte, T
Publicado: (2009)

Risk factors for acute exacerbations of COPD in a primary care population: a retrospective observational cohort study
por: Müllerová, Hana, et al.
Publicado: (2014)

Potential clinical and economic impact of optimised maintenance therapy on discharged patients with COPD after hospitalisation for an exacerbation in China
por: Salem, Ahmed, et al.
Publicado: (2021)

Eosinopenia as a biomarker for antibiotic use in COPD exacerbations: protocol for a retrospective hospital-based cohort study
por: Yang, Mei, et al.
Publicado: (2022)

EXAcerbations of COPD and their OutcomeS on CardioVascular diseases (EXACOS-CV) Programme: protocol of multicountry observational cohort studies
por: Nordon, Clementine, et al.
Publicado: (2023)

The IMPACT of triple versus dual single-inhaler therapy on exacerbations of COPD
por: Dobler, Claudia C.
Publicado: (2018)

Community determinants of COPD exacerbations in elderly patients in Lodz province, Poland: a retrospective observational Big Data cohort study
por: Kowalczyk, Anna, et al.
Publicado: (2022)

Mortality and readmission risk for hospitalised patients with acute exacerbation of COPD with and without spirometric obstruction: a longitudinal observational study in China
por: Ren, Xiaoxia, et al.
Publicado: (2023)

Single-inhaler triple therapy in symptomatic COPD patients: FULFIL subgroup analyses
por: Halpin, David M.G., et al.
Publicado: (2018)

Which patients with chronic obstructive pulmonary disease benefit from the addition of an inhaled corticosteroid to their bronchodilator? A cluster analysis
por: DiSantostefano, Rachael L, et al.
Publicado: (2013)

Linking e-health records, patient-reported symptoms and environmental exposure data to characterise and model COPD exacerbations: protocol for the COPE study
por: Moore, Elizabeth, et al.
Publicado: (2016)

Benefit/Risk Profile of Single-Inhaler Triple Therapy in COPD
por: Bourbeau, Jean, et al.
Publicado: (2021)

Vitamin D in the prevention of exacerbations of asthma in preschoolers (DIVA): protocol for a multicentre randomised placebo-controlled triple-blind trial
por: Jensen, Megan E, et al.
Publicado: (2019)

Prioritising outcomes for evaluating eosinophil-guided corticosteroid therapy among patients with acute COPD exacerbations requiring hospitalisation: a Delphi consensus study
por: Suehs, Carey Meredith, et al.
Publicado: (2020)

Prevalence and clinical implications of respiratory viruses in stable chronic obstructive pulmonary disease (COPD) and exacerbations: a systematic review and meta-analysis protocol
por: Kefala, Anastasia M, et al.
Publicado: (2020)

Patient characteristics associated with risk of first hospital admission and readmission for acute exacerbation of chronic obstructive pulmonary disease (COPD) following primary care COPD diagnosis: a cohort study using linked electronic patient records
por: Hunter, L C, et al.
Publicado: (2016)

Symptoms and exacerbations in asthma: an apparent paradox?
por: Morjaria, Jaymin B., et al.
Publicado: (2019)

Protocol for a systematic literature review and network meta-analysis of the clinical benefit of inhaled maintenance therapies in chronic obstructive pulmonary disease
por: Lewis, Adam, et al.
Publicado: (2019)

Efficacy and safety of 4 weeks' treatment with combined fluticasone furoate/vilanterol in a single inhaler given once daily in COPD: a placebo-controlled randomised trial
por: Lötvall, J, et al.
Publicado: (2012)

Impact of changes to reimbursement of fixed combinations of inhaled corticosteroids and long-acting β(2)-agonists in obstructive lung diseases: a population-based, observational study
por: Björnsdóttir, U S, et al.
Publicado: (2014)

Prometheus Assessed?
por: Goldfinch, Shaun
Publicado: (2012)

Protocol for a human in vivo model of acute cigarette smoke inhalation challenge in smokers with COPD: monitoring the nasal and systemic immune response using a network biology approach
por: Ross, Clare L, et al.
Publicado: (2015)

Effect of PIFR-based optimised inhalation therapy in patients recovering from acute exacerbation of chronic obstructive pulmonary disease: protocol of a prospective, multicentre, superiority, randomised controlled trial
por: Hua, Jianlan, et al.
Publicado: (2020)

Mother’s education and offspring asthma risk in 10 European cohort studies
por: Lewis, Kate Marie, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_u8g770drna2frhr023ogtq9qge